Nestabs Dha Kit
NDC Package 50967-317-30
Package Information
Nestabs Dha (sodium ascorbate, cholecalciferol, di-alpha-tocopheryl acetate, thiamine mononitrate, riboflavin, niacinamide, pyridoxine hcl, folic acid, cyanocobalamin, calcium formate, calcium carbonate, ferrous (ii) bis-glycinate chelate, potassium iodide, zinc oxide, choline bitartrate, with doconexent and icosapent) kits is i ndications and Usage: Nestabs DHA is indicated to provide vitamin/mineral and omega-3 fatty acid supplementation to women throughout pregnancy, during the postnatal for both lactating and nonlactating mothers. This formulation utilizes a kit delivery system. Marketed by Womens Choice Pharmaceuticals Llc, this product is identified by NDC 50967-317.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50967 - Womens Choice Pharmaceuticals Llc
- 50967-317 - Nestabs Dha
- 50967-317-30 - 4 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK
- 50967-317 - Nestabs Dha
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50967-317-30 identifies a specific commercial package of 4 blister pack in 1 carton / 1 kit in 1 blister pack of Nestabs Dha Prenatal Multi-vitamin/mineral Supplement With Dha/epa, a human prescription drug labeled by Womens Choice Pharmaceuticals Llc. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Womens Choice Pharmaceuticals Llc on February 01, 2011. The current certification is valid through December 31, 2026.
How is this Womens Choice Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50967031730. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 4 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.